By Manshi Mamtora
Publication Date: 2026-09-22 04:44:00
Iambic Therapeutics, an AI-driven drug discovery company backed by Nvidia (NVDA), filed for a U.S. initial public offering on Monday, seeking to list on the Nasdaq under the ticker IAM.
Nvidia-backed AI drugmaker Iambic Therapeutics seeks U.S. listing
